Model Medicines, Sanford Burnham Prebys forge AI-driven drug discovery partnership
AI drug discovery software company Model Medicines has signed a multi-target collaboration agreement with California-based Sanford Burnham Prebys Medical Discovery Institute for identifying and developing drugs for novel antiviral targets. The collaboration will make use of Model Medicines’ ActivPred AI Drug Discovery Platform, a drug, target, and disease agnostic digital chemistry engine, in conjunction with […]